Characterization of ACTN4 as a novel antiviral target against SARS-CoV-2.
Zhu M, Huang F, Sun H, Liu K, Chen Z, Yu B, Hao H, Liu H, Ding S, Zhang X, Liu L, Zhang K, Ren J, Liu Y, Liu H, Shan C, Guan W.
Zhu M, et al. Among authors: guan w.
Signal Transduct Target Ther. 2024 Sep 18;9(1):243. doi: 10.1038/s41392-024-01956-4.
Signal Transduct Target Ther. 2024.
PMID: 39289355
Free PMC article.